                         SEQUENCE LISTING

<110>  AstraZeneca AB
 
<120>  MCL-1 Inhibitors and Methods of Use Thereof

<130>  200601-WO-PCT

<150>  US 62/541,264
<151>  2017-08-04

<150>  US 62/479,489
<151>  2017-03-31

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Trp Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp Glu Phe Asn 
1               5                   10                  


